RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 22.20
-0.25 (-1.11%)
Aug 19, 2026, 11:11 AM CST
RBC Bioscience Market Cap
RBC Bioscience has a market cap or net worth of 276.91 million as of August 18, 2026. Its market cap has increased by 9.60% in one year.
Market Cap
276.91M
Enterprise Value
631.64M
Revenue
220.60M
Ranking
n/a
PE Ratio
13.18
Stock Price
22.20
ChartMarket Cap Chart
Since October 25, 2021, RBC Bioscience's market cap has decreased from 632.27M to 276.91M, a decrease of -56.20%. That is a compound annual growth rate of -15.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 320.44M | 33.23% |
| Dec 31, 2025 | 240.51M | -2.96% |
| Dec 31, 2024 | 247.83M | 17.90% |
| Dec 29, 2023 | 210.20M | 2.21% |
| Dec 30, 2022 | 205.66M | -55.24% |
| Dec 30, 2021 | 459.45M | -27.33% |
| Oct 25, 2021 | 632.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NatureWise Biotech & Medicals | 786.46M |
| Taiwan Advance Bio-Pharmaceutical | 783.00M |
| BioLASCO Taiwan | 760.68M |
| SynCore Biotechnology Co.,Ltd | 683.95M |
| MegaPro Biomedical | 666.63M |
| Neith | 633.14M |
| TaiwanJ Pharmaceuticals | 546.43M |
| Vectorite Biomedical | 538.39M |